Pontus Protein Concludes a Successful First Day Trading On The TSX.V Under The Ticker Symbol HULK.V
Posted on January 29, 2021
Vancouver, British Columbia, January 29, 2021 – Pontus Protein Ltd (“Pontus” or the “Company“) is pleased to announce the highly successful completion of its first day trading as a public company. Over 1.4 million shares were traded on the initial debut, with a resulting closing price of 0.75 per share.
Message from the CEO
CEO Connor Yuen stated: “We are extremely pleased with the interest and enthusiasm investors had in welcoming our company to the public markets. After an extensive period preparing to be publicly traded, our first day exceeded our expectations. Our work is far from over, and this is just the beginning, as we look forward to being able to execute on the vision of the company and become a leader in plant-based protein. There is a tailwind in this sector which our shareholders recognize as consumers look towards sustainable plant-based products.”
Plant-Based Protein Powder Market
The plant-based protein powder developed by the Company is a premium entry into the global protein supplements market. This market is currently valued at USD $15 Billion and will grow to USD $20 Billion by 2025 (source: Grand View Research 2018). The growth is fueled by more North Americans reducing or eliminating animal products. The North American Plant-based Protein Market is anticipated to grow at a CAGR of 14% from 2019 through 2025.
Investor Relations Update
The Company is pleased to announce that it has retained Edge Growth Holdings Corporation (“Edge Communications Group” or “Edge”) for strategic investor relations and capital markets communications services. Under the terms of the three-month agreement, the Company will pay Edge a monthly fee of $10,000 and grant to Kevan Matheson, the principal of Edge, 50,000 incentive stock options. Other than the options to be granted and 100,000 shares, neither Edge, Kevan Matheson, nor any employees of Edge have any direct or indirect interest in Pontus or its securities.
About Pontus Protein Ltd.
Pontus Protein Ltd. is a Vancouver, B.C. based agricultural technology company that will enable millions to rethink their food choices while helping people do the world a world of good. By offering sustainably grown plant based food options that are nutritious and delicious, we’re helping this kind of diet become the norm.
Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.
To learn more, please visit www.pontuswaterlentils.com.
On behalf of the Board of Directors
Connor Yuen, CEO
Pontus Protein Ltd.
For more information, please contact:
Connor Yuen Chief
For further information:
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the anticipated use of proceeds of the Offering, Including those from the Second Tranche, by the Company and Pontus’ ability to revolutionize the plant based sector and enable millions to rethink their food choices. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive TSX Venture Exchange approval for the closing of the remainder of the Offering, Pontus’ inability to close further tranches of the Offering, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete Pontus’ Surrey Facility, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.